Empty Capsules Market, 2012 to 2023
Increase in the preference for vegetarian based empty capsules by various manufacturers, rise in the adoption of vegetarian empty capsules by the vegan groups, increase in the technological advancements, and attractive capsule design is the key factors expected to propel the empty capsules market growth. Furthermore, rise in consumer demand for capsules over tablets, and various advantages of capsules such as masking of unpleasant taste and odour of the drugs, increase the bioavailability and stability of the drugs expected to fuel the empty capsules market over the forecast period. However, the rise in prices of raw materials of empty capsules and socio-culture issues regarding the administration of gelatin capsules anticipated restraining the empty capsules market over the forecast timeframe.
Global Empty Capsules Market
Empty capsules are made up of gelatin, derived from the animal protein (such as pork skin, fish bones, and animal skin and bones) and plant polysaccharides (HPMC, pullulan, starch etc.). Empty capsules contain two parts namely a lower diameter or body filled with the various drugs and sealed with higher-diameter or cap. Various prescribed and OTC drugs, herbal drugs, and nutritional substances can be dispensed by filling in the empty capsules. Apart from this, empty capsules are also used to fill semi-solid and liquid dosage forms, especially for the drugs which have poor bioavailability, critical stability, poor water solubility, and low melting points etc. The advantages of the empty capsules are that they are low sensitive to oxygen permeability and have constant capsule dimensions.
Empty capsule market is segmented based on product type, application, route of administration, and end user
Based on the product type, empty capsules market is segmented into the following:
Gelatin or animal source capsules
Bovine source
Pork source
Bone meal
Others
Non-gelatin or plant source capsules
HPMC
Starch
Pullulan
Based on the application, empty capsules market is segmented into the following:
Antibiotics
Vitamins
Anti-inflammatory
Others
Based on the route of administration, empty capsules market is segmented into the following:
Oral
Inhalation
Others
Based on the end user, empty capsules market is segmented into the following:
Pharmaceutical and Biotechnology companies
Nutraceutical companies
Others
Global empty capsules market is in the developed stage with the availability of both gelatin and non-gelatin based capsules. Several local and international players are manufacturing the empty capsules with technological advancements such as enteric coated and extended-release capsules, which release the drug for a long time. The usage of capsules is increased owing to its advantages such as taste and odour masking ability of the drugs and protect the drug from unfavourable atmospheric conditions. Acquisitions and mergers, collaborations, technological advancements, and diversification of business segment around the globe are some strategies followed by the companies to increase their revenue in the empty capsules market. For instance, in December 2016, Lonza Group AG has acquired the Capsugel from the KKR & Co LP for broadening its product range.
Geographically, empty capsule market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. Increase in the R&D activities for various therapeutic drugs, a rise in the prevalence of various diseases due to change in lifestyle, increase in the healthcare expenditure, and rise in per capita income are anticipated to fuel the empty capsules market in the North America region. Moreover, Europe holds a dominant share, which is attributed to technological advancements in the empty capsules, increase in the healthcare expenditure, an increase in the demand for capsule consumption over the tablets is expected to bolster the empty capsules market in the Europe region. Asia Pacific is anticipated grow at significant rate owing to increase in the number of pharmaceutical and nutraceutical companies, ease of regulatory approvals in the nutraceutical industries, rise in healthcare expenditure, an increase in the prevalence of various infectious diseases might fuel the growth of the empty capsules market.
Some of the players in empty capsules market are ACG Worldwide (India), CapsCanada Corporation (Canada), Suheung Co., Ltd. (Korea), Qualicaps, Inc. (U.S.), Snail Pharma Industry Co. (China), Roxlor LLC (U.S.), Medi-Caps Ltd. (India), Lonza Group AG (Switzerland) and Bright Pharma Caps (U.S.) to name a few.
In February 2016, Qualicaps has acquired Genix Industria Farmaceutica Ltd. for the development and commercialization of empty capsules
Global Empty Capsules Market
Empty capsules are made up of gelatin, derived from the animal protein (such as pork skin, fish bones, and animal skin and bones) and plant polysaccharides (HPMC, pullulan, starch etc.). Empty capsules contain two parts namely a lower diameter or body filled with the various drugs and sealed with higher-diameter or cap. Various prescribed and OTC drugs, herbal drugs, and nutritional substances can be dispensed by filling in the empty capsules. Apart from this, empty capsules are also used to fill semi-solid and liquid dosage forms, especially for the drugs which have poor bioavailability, critical stability, poor water solubility, and low melting points etc. The advantages of the empty capsules are that they are low sensitive to oxygen permeability and have constant capsule dimensions.
Empty capsule market is segmented based on product type, application, route of administration, and end user
Based on the product type, empty capsules market is segmented into the following:
Gelatin or animal source capsules
Bovine source
Pork source
Bone meal
Others
Non-gelatin or plant source capsules
HPMC
Starch
Pullulan
Based on the application, empty capsules market is segmented into the following:
Antibiotics
Vitamins
Anti-inflammatory
Others
Based on the route of administration, empty capsules market is segmented into the following:
Oral
Inhalation
Others
Based on the end user, empty capsules market is segmented into the following:
Pharmaceutical and Biotechnology companies
Nutraceutical companies
Others
Global empty capsules market is in the developed stage with the availability of both gelatin and non-gelatin based capsules. Several local and international players are manufacturing the empty capsules with technological advancements such as enteric coated and extended-release capsules, which release the drug for a long time. The usage of capsules is increased owing to its advantages such as taste and odour masking ability of the drugs and protect the drug from unfavourable atmospheric conditions. Acquisitions and mergers, collaborations, technological advancements, and diversification of business segment around the globe are some strategies followed by the companies to increase their revenue in the empty capsules market. For instance, in December 2016, Lonza Group AG has acquired the Capsugel from the KKR & Co LP for broadening its product range.
Geographically, empty capsule market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. Increase in the R&D activities for various therapeutic drugs, a rise in the prevalence of various diseases due to change in lifestyle, increase in the healthcare expenditure, and rise in per capita income are anticipated to fuel the empty capsules market in the North America region. Moreover, Europe holds a dominant share, which is attributed to technological advancements in the empty capsules, increase in the healthcare expenditure, an increase in the demand for capsule consumption over the tablets is expected to bolster the empty capsules market in the Europe region. Asia Pacific is anticipated grow at significant rate owing to increase in the number of pharmaceutical and nutraceutical companies, ease of regulatory approvals in the nutraceutical industries, rise in healthcare expenditure, an increase in the prevalence of various infectious diseases might fuel the growth of the empty capsules market.
Some of the players in empty capsules market are ACG Worldwide (India), CapsCanada Corporation (Canada), Suheung Co., Ltd. (Korea), Qualicaps, Inc. (U.S.), Snail Pharma Industry Co. (China), Roxlor LLC (U.S.), Medi-Caps Ltd. (India), Lonza Group AG (Switzerland) and Bright Pharma Caps (U.S.) to name a few.
In February 2016, Qualicaps has acquired Genix Industria Farmaceutica Ltd. for the development and commercialization of empty capsules
1. EXECUTIVE SUMMARY
2. GLOBAL EMPTY CAPSULES MARKET INTRODUCTION
2.1. Global Empty Capsules Market – Taxonomy
2.2. Global Empty Capsules Market –Definitions
2.2.1. Product
2.2.2. Application
2.2.3. Route of Administration
2.2.4. End-User
3. GLOBAL EMPTY CAPSULES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Empty Capsules Market Dynamics – Factors Impact Analysis
3.6. Global Empty Capsules Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Gelatin or animal source capsules
5.1.1. Bovine source
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Pork source
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Bone meal
5.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Others
5.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Non-gelatin or plant source capsules
5.2.1. HPMC
5.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Starch
5.2.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Pullulan
5.2.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
6. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antibiotics
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Vitamins
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Anti-inflammatory
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Oral
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Inhalation
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Pharmaceutical and Biotechnology companies
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Nutraceutical companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Region, 2017 – 2023
10. NORTH AMERICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Gelatin or animal source capsules
10.1.1.1. Bovine source
10.1.1.2. Pork source
10.1.1.3. Bone meal
10.1.1.4. Others
10.1.2. Non-gelatin or plant source capsules
10.1.2.1. HPMC
10.1.2.2. Starch
10.1.2.3. Pullulan
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Antibiotics
10.2.2. Vitamins
10.2.3. Anti-inflammatory
10.2.4. Others
10.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Inhalation
10.3.3. Others
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology companies
10.4.2. Nutraceutical companies
10.4.3. Others
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
10.7. North America Empty Capsules Market Dynamics – Trends
11. EUROPE EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Gelatin or animal source capsules
11.1.1.1. Bovine source
11.1.1.2. Pork source
11.1.1.3. Bone meal
11.1.1.4. Others
11.1.2. Non-gelatin or plant source capsules
11.1.2.1. HPMC
11.1.2.2. Starch
11.1.2.3. Pullulan
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Antibiotics
11.2.2. Vitamins
11.2.3. Anti-inflammatory
11.2.4. Others
11.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Inhalation
11.3.3. Others
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology companies
11.4.2. Nutraceutical companies
11.4.3. Others
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
11.7. Europe Empty Capsules Market Dynamics – Trends
12. ASIA-PACIFIC EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Gelatin or animal source capsules
12.1.1.1. Bovine source
12.1.1.2. Pork source
12.1.1.3. Bone meal
12.1.1.4. Others
12.1.2. Non-gelatin or plant source capsules
12.1.2.1. HPMC
12.1.2.2. Starch
12.1.2.3. Pullulan
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Antibiotics
12.2.2. Vitamins
12.2.3. Anti-inflammatory
12.2.4. Others
12.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Inhalation
12.3.3. Others
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology companies
12.4.2. Nutraceutical companies
12.4.3. Others
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
12.7. Europe Empty Capsules Market Dynamics – Trends
13. LATIN AMERICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Gelatin or animal source capsules
13.1.1.1. Bovine source
13.1.1.2. Pork source
13.1.1.3. Bone meal
13.1.1.4. Others
13.1.2. Non-gelatin or plant source capsules
13.1.2.1. HPMC
13.1.2.2. Starch
13.1.2.3. Pullulan
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Antibiotics
13.2.2. Vitamins
13.2.3. Anti-inflammatory
13.2.4. Others
13.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Inhalation
13.3.3. Others
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology companies
13.4.2. Nutraceutical companies
13.4.3. Others
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
13.7. Latin America Empty Capsules Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Gelatin or animal source capsules
14.1.1.1. Bovine source
14.1.1.2. Pork source
14.1.1.3. Bone meal
14.1.1.4. Others
14.1.2. Non-gelatin or plant source capsules
14.1.2.1. HPMC
14.1.2.2. Starch
14.1.2.3. Pullulan
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Antibiotics
14.2.2. Vitamins
14.2.3. Anti-inflammatory
14.2.4. Others
14.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Inhalation
14.3.3. Others
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology companies
14.4.2. Nutraceutical companies
14.4.3. Others
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
14.7. MEA Empty Capsules Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. ACG Worldwide (India)
15.2.2. CapsCanada Corporation (Canada)
15.2.3. Suheung Co., Ltd. (Korea)
15.2.4. Qualicaps, Inc. (U.S.)
15.2.5. Snail Pharma Industry Co. (China)
15.2.6. Roxlor LLC (U.S.)
15.2.7. Medi-Caps Ltd. (India)
15.2.8. Lonza Group AG (Switzerland)
15.2.9. Bright Pharma Caps (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL EMPTY CAPSULES MARKET INTRODUCTION
2.1. Global Empty Capsules Market – Taxonomy
2.2. Global Empty Capsules Market –Definitions
2.2.1. Product
2.2.2. Application
2.2.3. Route of Administration
2.2.4. End-User
3. GLOBAL EMPTY CAPSULES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Empty Capsules Market Dynamics – Factors Impact Analysis
3.6. Global Empty Capsules Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Gelatin or animal source capsules
5.1.1. Bovine source
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Pork source
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Bone meal
5.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Others
5.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Non-gelatin or plant source capsules
5.2.1. HPMC
5.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Starch
5.2.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Pullulan
5.2.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
6. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antibiotics
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Vitamins
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Anti-inflammatory
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Oral
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Inhalation
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Pharmaceutical and Biotechnology companies
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Nutraceutical companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL EMPTY CAPSULES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Region, 2017 – 2023
10. NORTH AMERICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Gelatin or animal source capsules
10.1.1.1. Bovine source
10.1.1.2. Pork source
10.1.1.3. Bone meal
10.1.1.4. Others
10.1.2. Non-gelatin or plant source capsules
10.1.2.1. HPMC
10.1.2.2. Starch
10.1.2.3. Pullulan
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Antibiotics
10.2.2. Vitamins
10.2.3. Anti-inflammatory
10.2.4. Others
10.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Inhalation
10.3.3. Others
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology companies
10.4.2. Nutraceutical companies
10.4.3. Others
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
10.7. North America Empty Capsules Market Dynamics – Trends
11. EUROPE EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Gelatin or animal source capsules
11.1.1.1. Bovine source
11.1.1.2. Pork source
11.1.1.3. Bone meal
11.1.1.4. Others
11.1.2. Non-gelatin or plant source capsules
11.1.2.1. HPMC
11.1.2.2. Starch
11.1.2.3. Pullulan
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Antibiotics
11.2.2. Vitamins
11.2.3. Anti-inflammatory
11.2.4. Others
11.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Inhalation
11.3.3. Others
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology companies
11.4.2. Nutraceutical companies
11.4.3. Others
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
11.7. Europe Empty Capsules Market Dynamics – Trends
12. ASIA-PACIFIC EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Gelatin or animal source capsules
12.1.1.1. Bovine source
12.1.1.2. Pork source
12.1.1.3. Bone meal
12.1.1.4. Others
12.1.2. Non-gelatin or plant source capsules
12.1.2.1. HPMC
12.1.2.2. Starch
12.1.2.3. Pullulan
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Antibiotics
12.2.2. Vitamins
12.2.3. Anti-inflammatory
12.2.4. Others
12.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Inhalation
12.3.3. Others
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology companies
12.4.2. Nutraceutical companies
12.4.3. Others
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
12.7. Europe Empty Capsules Market Dynamics – Trends
13. LATIN AMERICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Gelatin or animal source capsules
13.1.1.1. Bovine source
13.1.1.2. Pork source
13.1.1.3. Bone meal
13.1.1.4. Others
13.1.2. Non-gelatin or plant source capsules
13.1.2.1. HPMC
13.1.2.2. Starch
13.1.2.3. Pullulan
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Antibiotics
13.2.2. Vitamins
13.2.3. Anti-inflammatory
13.2.4. Others
13.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Inhalation
13.3.3. Others
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology companies
13.4.2. Nutraceutical companies
13.4.3. Others
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
13.7. Latin America Empty Capsules Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA EMPTY CAPSULES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Gelatin or animal source capsules
14.1.1.1. Bovine source
14.1.1.2. Pork source
14.1.1.3. Bone meal
14.1.1.4. Others
14.1.2. Non-gelatin or plant source capsules
14.1.2.1. HPMC
14.1.2.2. Starch
14.1.2.3. Pullulan
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Antibiotics
14.2.2. Vitamins
14.2.3. Anti-inflammatory
14.2.4. Others
14.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Inhalation
14.3.3. Others
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology companies
14.4.2. Nutraceutical companies
14.4.3. Others
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Empty Capsules Market - Opportunity Analysis Index, By Product, By Application, By Route of Administration, By End-User, and Country, 2017 – 2023
14.7. MEA Empty Capsules Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. ACG Worldwide (India)
15.2.2. CapsCanada Corporation (Canada)
15.2.3. Suheung Co., Ltd. (Korea)
15.2.4. Qualicaps, Inc. (U.S.)
15.2.5. Snail Pharma Industry Co. (China)
15.2.6. Roxlor LLC (U.S.)
15.2.7. Medi-Caps Ltd. (India)
15.2.8. Lonza Group AG (Switzerland)
15.2.9. Bright Pharma Caps (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
